Changes to driving laws + EU funding into T1 project |
|
|
|
The European Commission announced last week that they will ask the DVLA to change their driving laws for people with diabetes.
The current guidelines do not differentiate between daytime and night-time episodes of severe hypoglycemia which campaigners have argued is unfair.
The DVLA has been asked to make the necessary legislative changes by January 2018. This means that licensing can be considered for people with diabetes on a case-by-case basis, based on medical evidence and risk assessments.
Elsewhere, the EU is funding a project to mass produce three-dimensional cellular structures of insulin-producing cells to treat type 1 diabetes.
These cells, known as organoids, have already been shown to work in mice, and European researchers hope this treatment could eventually free people from lifelong insulin therapy.
Maggot debridement therapy (MDT) is another diabetes treatment that was reported on last week. In a new review, researchers found it could enhance the speed of diabetes wound healing.
This increase in speed was achieved by genetically modifying the maggots to release a hormone which activate stimulates cell growth and wound healing. The researchers believe MDT could provide an affordable treatment to people with diabetes who live in less wealthy countries and do not have access to more expensive treatments. |
|